(Q44969208)

7 December 2017

title

Understanding the latest advances in pharmacologic interventions for Alzheimer's disease (English)

1 reference

7 December 2017

0 references

Christopher H van Dyck

series ordinal

1

1 reference

7 December 2017

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

9

1 reference

7 December 2017

issue

7 Suppl 5

1 reference

7 December 2017

page(s)

24-28

1 reference

No interaction of memantine with acetylcholinesterase inhibitors approved for clinical use.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900024780

7 January 2021

10.1017/S1092852900024780

Identifiers

DOI

0 references

1 reference